What is the treatment for ringworm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Ringworm

For ringworm (tinea corporis), topical antifungal agents are the first-line treatment, with oral therapy reserved for extensive, resistant, or complicated cases. 1

First-Line Treatment

Topical Therapy

  • Preferred agents:

    • Azole antifungals (clotrimazole 1%, miconazole)
    • Allylamine antifungals (terbinafine 1%, naftifine 1%)
    • Apply once or twice daily for 2-4 weeks 1, 2
    • Continue treatment for at least 1 week after clinical improvement to prevent relapse
  • Evidence of efficacy:

    • Clotrimazole 1% shows significantly higher mycological cure rates compared to placebo (RR 2.87) 1
    • Terbinafine shows significantly higher clinical cure rates compared to placebo (RR 4.51) 1
    • Naftifine 1% demonstrates superior mycological cure (RR 2.38) and clinical cure (RR 2.42) compared to placebo 1

Second-Line/Extensive Disease Treatment

Oral Therapy

For extensive disease, multiple lesions, immunocompromised patients, or treatment failures:

  • Fluconazole:

    • 50-100 mg daily or 150 mg once weekly for 2-3 weeks 3
  • Itraconazole:

    • 100 mg daily for 2 weeks or 200 mg daily for 7 days 3
  • Terbinafine:

    • 250 mg daily for 1-2 weeks 3
  • Griseofulvin (ultramicrosize):

    • Adults: 375 mg daily (single dose or divided doses) 4
    • Children: 7.3 mg/kg/day 4
    • Duration: 2-4 weeks for tinea corporis 4

Special Considerations

Tinea Capitis (Scalp Ringworm)

Requires systemic therapy:

  • First-line options:

    • Griseofulvin:

      • <50 kg: 15-20 mg/kg/day for 6-8 weeks
      • 50 kg: 1 g/day for 6-8 weeks 5

    • Terbinafine:

      • <20 kg: 62.5 mg/day for 2-4 weeks
      • 20-40 kg: 125 mg/day for 2-4 weeks
      • 40 kg: 250 mg/day for 2-4 weeks 5

  • Second-line option:

    • Itraconazole: 50-100 mg/day for 4 weeks, or 5 mg/kg/day for 2-4 weeks 5

Tinea Cruris (Groin)

  • Similar treatment approach as tinea corporis
  • Topical therapy is first-line 1
  • Keep area dry and wear loose-fitting clothing

Tinea Pedis (Athlete's Foot)

  • Topical therapy for 4-8 weeks 4
  • Consider oral therapy for chronic or extensive cases

Important Clinical Pearls

  1. Diagnosis confirmation: While treatment can be initiated based on clinical appearance, consider microscopy with potassium hydroxide (KOH) preparation or culture for confirmation in atypical or resistant cases 4

  2. General hygiene measures:

    • Keep affected areas clean and dry
    • Avoid sharing personal items (towels, clothing, combs)
    • Treat family members or close contacts if infected 5
  3. Treatment failures:

    • Consider poor compliance
    • Evaluate for incorrect diagnosis
    • Consider fungal resistance
    • Check for ongoing sources of reinfection
  4. Combination therapy:

    • Some evidence suggests azole-steroid combinations may provide faster symptomatic relief but should be used cautiously as they may mask symptoms while infection persists 1
  5. Duration of therapy:

    • Continue treatment until clinical and mycological cure
    • Extend treatment for 1-2 weeks beyond clinical resolution to prevent relapse

By following this treatment algorithm, most cases of ringworm will resolve completely with minimal risk of recurrence or complications.

References

Research

Topical antifungal treatments for tinea cruris and tinea corporis.

The Cochrane database of systematic reviews, 2014

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.